Ausgabe 7/2006
Inhalt (14 Artikel)
Tumor immune escape mechanisms: impact of the neuroendocrine system
Kerstin Lang, Frank Entschladen, Corinna Weidt, Kurt S. Zaenker
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
Brian S. Choi, Paul M. Sondel, Jacquelyn A. Hank, Heidi Schalch, Jacek Gan, David M. King, Kari Kendra, David Mahvi, Li-Yin Lee, KyungMann Kim, Mark R. Albertini
Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer
Kanji Takahashi, Hideyoshi Toyokawa, Soichiro Takai, Sohei Satoi, Hiroaki Yanagimoto, Naoyoshi Terakawa, Hiroshi Araki, A-Hon Kwon, Yasuo Kamiyama
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3
Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, Grit Lorenczewski, Klaus Brischwein, Sandra Lippold, Antonio da Silva, Mathias Locher, Roman Kischel, Ralf Lutterbüse, Peter Kufer, Patrick A. Baeuerle
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen
Irma M. Sainz, Irma Isordia-Salas, Ricardo G. Espinola, Walter K. Long, Robin A. Pixley, Robert W. Colman
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes
Monika Baj-Krzyworzeka, Rafał Szatanek, Kazimierz Węglarczyk, Jarosław Baran, Barbara Urbanowicz, Piotr Brański, Mariusz Z. Ratajczak, Marek Zembala
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
Margarita Salcedo, Nadège Bercovici, Rachel Taylor, Pierre Vereecken, Séverine Massicard, Dominique Duriau, Frédérique Vernel-Pauillac, Aurélie Boyer, Véronique Baron-Bodo, Eric Mallard, Jacques Bartholeyns, Béatrice Goxe, Nathalie Latour, Sophie Leroy, Didier Prigent, Philippe Martiat, François Sales, Marianne Laporte, Catherine Bruyns, Jean-Loup Romet-Lemonne, Jean-Pierre Abastado, Frédéric Lehmann, Thierry Velu
T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)
Astrid Marta Olsnes, Dmitri Motorin, Anita Ryningen, Andrey Y. Zaritskey, Øystein Bruserud
MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo
Wei Ge, Yan-Fang Sui, Dao-Cheng Wu, Yu-Jing Sun, Guang-Sheng Chen, Zeng-Shan Li, Shao-Yan Si, Pei-Zhen Hu, Yang Huang, Xiu-Min Zhang
Defining MHC class II T helper epitopes for WT1 tumor antigen
Hiroya Kobayashi, Toshihiro Nagato, Naoko Aoki, Keisuke Sato, Shoji Kimura, Masatoshi Tateno, Esteban Celis
Therapeutic efficacy of tumor-targeted IL2 in LTα−/− mice depends on conditioned T cells
David Schrama, Heike Voigt, Andreas O. Eggert, Rong Xiang, Ralph A. Reisfeld, Jürgen C. Becker
A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA–A24 carcinoma cells
Sabrina Ottaviani, Didier Colau, Pierre van der Bruggen, Pierre van der Bruggen
Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats
Jin-Cherng Chen, Yun Chen, Jiann-Ming Wu, Yen-Hao Su, Kuo-Feng Tai, Sheng-Hong Tseng
Fifth European progress in vaccination against cancer conference, PIVAC 5
Federica Cavallo, Constantin N. Baxevanis